Our agenda and speakers

Meet our conference co-chairs

Explore our speakers

Irene Ghobrial

Professor of Medicine, Harvard Medical School

Pre-cancer biology & interception opportunities session co-chair

Simon Leedham

Professor, University of Oxford

Pre-cancer biology & interception opportunities session co-chair

Melissa Davis

Director, Institute of Translational Genomic Medicine Georgia Research Alliance, Morehouse School of Medicine

Integrated view of inequalities in cancer risk and incidence; how to achieve equitable cancer prevention session co-chair

Neerja Bhatla

Head, Gynaecologic Oncology, All India Institute of Medical Sciences, New Delhi

Integrated view of inequalities in cancer risk and incidence; how to achieve equitable cancer prevention session co-chair

Walid Khaled

Professor of Tumour Initiation, Cambridge Stem Cell Institute

The convergence of ageing, genetics and cancer risk/genesis; new opportunities for prevention session co-chair

Ashani Weeraratna

Bloomberg Distinguished Professor of Cancer Biology, John Hopkins

The convergence of ageing, genetics and cancer risk/genesis; new opportunities for prevention session co-chair

Pamela Goodwin

Professor of Medicine, University of Toronto, Sinai Health

Implementation of precision prevention interventions using repurposed drugs - can this realistically change practice session co-chair

Eva Szabo

Chief Program Officer, National Cancer Institute

Implementation of precision prevention interventions using repurposed drugs - can this realistically change practice session co-chair

08:00 – 09:30	Registration, networking and poster set-up
09:30 – 09:50	Welcome from the partners
09:50 – 09:55	Welcome Sarah Blagden, University of Oxford
09:55 – 10:40	Keynote address Chair: Sarah Blagden, University of Oxford Speaker: Charles Swanton, Francis Crick Institute
10:40 – 11:10	Networking break and exhibition
11:10 – 13:10	Pre-cancer biology & interception opportunities Co-chairs: Irene Ghobrial, Harvard Medical School Simon Leedham, University of Oxford
13:10 – 14:20	Lunch, exhibition and poster viewing
14:20 – 14:50	Emerging researchers’ flash talks Talks will be selected from abstracts
14:55 – 15;40	Panel session: Immune System Insights: The Role of Immune Dysfunction in Cancer Development and Prevention
15:40 – 16:10	Networking break and exhibition
16:10 – 18:10	Integrated view of inequalities in cancer risk and incidence; how to achieve equitable cancer prevention? Co-chairs: Melissa Davis, Morehouse School of Medicine Neerja Bhatla, AIIMS (All India Institute of Medical Sciences, New Delhi)
18:10	Closing remarks
18:10 – 19:15	Networking reception and poster viewing

08:15 – 09:00	Light breakfast
09:00 – 09:05	Opening remarks Elizabeth Jaffee, Johns Hopkins University School of Medicine
09:05 – 09:50	Panel session: defining the Pre-Cancer State to enable innovations in early identification and preventive intervention
09:50 – 10:10	Emerging researchers’ flash talks Talks will be selected from abstracts
10:10 – 10:40	Networking break and exhibition
10:40 – 12:40	The convergence of ageing, genetics and cancer risk/genesis; new opportunities for prevention Co-chairs: Walid Khaled, Cambridge Stem Cell Institute Ashani Weeraratna, John Hopkins
12:40 – 13:50	Lunch, exhibition and poster viewing
13:50 - 14:35	Keynote address Chair: Elizabeth Jaffee, Johns Hopkins University School of Medicine Speaker: Allan Balmain, University of California San Francisco
14:40 – 15:15	Debate: cancer prevention research should focus on understanding cancer risk, genesis and targets in childhood and adolescence - waiting until late adulthood when risk is highest is too late to effectively prevent.
15:15 – 15:45	Networking break and exhibition
15:45 – 16:45	Panel session: defining High-Risk in Cancer Prevention: A Patient and Public Perspective
16:45 – 17:00	Closing remarks
17:00 – 18:00	Networking drinks and poster session
18:30 – late	Networking dinner

08:30 – 09:00	Light breakfast
09:00 – 09:05	Opening remarks Marc Gunter, Imperial College London
09:05 – 09:20	American Cancer Society Atlas launch
09:20 – 11:20	Implementation of precision prevention interventions using repurposed drugs - can this realistically change practice Co-chairs: Pamela Goodwin, Sinai Health Eva Szabo, National Cancer Institute
11:20 – 11:50	Networking break and exhibition
11:50 – 12:10	Emerging researchers’ flash talks Talks will be selected from abstracts
12:15 – 13:00	Fireside chat
13:00 – 14:00	Lunch and exhibition
14:00 – 14:35	Debate session
14:40 – 15:30	Panel session: can we ever really implement cancer prevention in the general population?
15:30 – 15:45	Comfort break
15:45 – 16:30	Keynote address Chair: Marc Gunter, Imperial College London Speaker: Elisabete Weiderpass, International Agency for Research on Cancer
16:30 – 16:50	Closing remarks and conference close

Our agenda and speakers

On this page:

Meet our conference co-chairs

Sarah Blagden

Marc Gunter

Elizabeth Jaffee

Explore our agenda

Wednesday 25 June

Thursday 26 June

Friday 27 June

Meet our keynote speakers

Allan Balmain

Charles Swanton

Elisabete Weiderpass